港股公告掘金 |三花智控发盈喜 预期年度归母净利同比增长25%-50%

Major Events - Xiansheng Pharmaceutical (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate) [1] - Cloudwalk Technology (09678) released the "Shanhai·Zhi Medical Model 5.0" version, a large model for the medical field [1] - Zhongchuang Zhiling (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership for external investment activities [1] - Brain Dynamics Aurora-B (06681) participates in a national key research project and has been approved for a key laboratory in digital healthcare for cognitive disorders in Beijing [1] - Dipo Technology (01384) entered into a strategic cooperation agreement with Muxi Co., Ltd. [1] - Shimao Services (00873) intends to establish a partnership with Huludao Yongsheng [1] - Hansai Aitai-B (03378) received 3,074.09 times subscription for its public offering in Hong Kong, with a share price of HKD 32 [1] - Qingsong Health (02661) received 1,421.47 times subscription for its public offering in Hong Kong, with a share price of HKD 22.68 [1] - Nobi Kan (02635) received 188.74 times subscription for its public offering in Hong Kong, with a share price of HKD 80 [1] Operating Performance - Sanhua Intelligent Controls (02050) issued a profit warning, expecting annual net profit attributable to shareholders to increase by 25%-50% year-on-year [1] - Cathay Pacific Airways (00293) reported 2.5304 million passengers in November, a year-on-year increase of 26% [1] - Tobo (06110) reported a high single-digit decline in total sales for retail and wholesale business in the third quarter year-on-year [1]